Aphria (APHA) Alert: Johnson Fistel Investigates Aphria Inc.; Investors Suffering Losses Encouraged to Contact Firm
SAN DIEGO- PRNewswire —December 4, 2018
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Aphria Inc. (“Aphria”) (NYSE: APHA). Aphria produces and sells medical cannabis in Canada and internationally.
On December 3, 2018, Quintessential Capital Management and Hindenburg Research published a report claiming, among other things, that the Company’s recent acquisitions in Latin America were part of a series of transactions designed to enrich Company insiders and that these acquisitions lacked established operations.
Following this news, Aphria’s share price fell over 23%, to close at $6.05 per share on December 3, 2018. In pre-market-trading on December 4, 2018, shares of Aphria stock continue to fall, and is currently down over 14%.
If you have information that could assist in this investigation, including past employees and others, or if you are a Aphrias shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) by email or phone at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [click here to join this action], if you purchased Aphria stock on the NYSE. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.